NCT01683721View on ClinicalTrials.gov

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Obstructive Sleep Apnea
Trial Locations (2)

33707

RECRUITING

St. Petersburg Sleep Disorders Center, St. Petersburg

75231

RECRUITING

Sleep Medicine Associates of Texas (SMAT), Dallas

Sponsors

Lead Sponsor

ApniCure, Inc.
All Listed Sponsors
lead

ApniCure, Inc.

INDUSTRY

NCT01683721 - Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA) | Biotech Hunter | Biotech Hunter